Sulforaphane Exhibits Cytotoxic Effects against Primary Effusion Lymphoma Cells by Suppressing p38MAPK and AKT Phosphorylation.

In conclusion, the anti-proliferative effects of SFN indicate its potential as a new substance for the treatment of PEL.
PMID: 31787726 [PubMed - in process]

Source: Biological and Pharmaceutical Bulletin - December 5, 2019 Category: Drugs & Pharmacology Authors: Ishiura Y, Ishimaru H, Watanabe T, Fujimuro M Tags: Biol Pharm Bull Source Type: research